pyridoxamine has been researched along with Kidney Diseases in 5 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " By contrast, renal damage was aggravated when PM was combined with ACEi." | 1.35 | Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats. ( Navis, G; van Goor, H; Waanders, F, 2008) |
| "PM inhibited AGE/ALE formation and hyperlipidemia and protected against renal and vascular pathology in a nondiabetic model." | 1.32 | The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats. ( Alderson, NL; Baynes, JW; Beattie, RJ; Chachich, ME; Nachtigal, M; Thorpe, SR; Youssef, NN, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waanders, F | 2 |
| van Goor, H | 2 |
| Navis, G | 2 |
| Alderson, NL | 1 |
| Chachich, ME | 1 |
| Youssef, NN | 1 |
| Beattie, RJ | 1 |
| Nachtigal, M | 1 |
| Thorpe, SR | 1 |
| Baynes, JW | 1 |
| Del Vecchio, L | 1 |
| van den Berg, E | 1 |
| Nagai, R | 1 |
| van Veen, I | 1 |
| Swaminathan, S | 1 |
| Shah, SV | 1 |
1 review available for pyridoxamine and Kidney Diseases
| Article | Year |
|---|---|
Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
Topics: Biomarkers; Chronic Disease; Diabetic Nephropathies; Disease Progression; Drugs, Investigational; Gl | 2008 |
4 other studies available for pyridoxamine and Kidney Diseases
| Article | Year |
|---|---|
Adverse renal effects of the AGE inhibitor pyridoxamine in combination with ACEi in non-diabetic adriamycin-induced renal damage in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Doxorubicin; Drug Interactions; D | 2008 |
The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Topics: Animals; Aorta; Arginine; Blood Glucose; Blood Pressure; Collagen; Female; Glycation End Products, A | 2003 |
American society of nephrology-36th annual meeting and renal week 2003.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antihypertensive Agents; Calcium; Diabetic Nephr | 2004 |
Renoprotective effects of the AGE-inhibitor pyridoxamine in experimental chronic allograft nephropathy in rats.
Topics: Animals; Chronic Disease; Glycation End Products, Advanced; Kidney Diseases; Kidney Transplantation; | 2008 |